Tildacerfont-d8
Tildacerfont-d8 (SPR001-d8) is a deuterium labeled Tildacerfont (HY-113603) . Tildacerfont is a potent and orally active corticotrophin-releasing factor type 1 (CRF1) receptort antagonis. Tildacerfont effectively reduces adrenocorticotropic hormone (ACTH) and adrenal androgen levels. Tildacerfont has favourable safety profile. Tildacerfont can be used for researching congenital adrenal hyperplasia[1].
Product Specifications
CAS Number
[2762751-36-8]
Product Name Alternative
SPR001-d8; LY2371712-d8
UNSPSC
12352005
Target
CRFR; Isotope-Labeled Compounds
Related Pathways
GPCR/G Protein; Others
Field of Research
Cancer
Purity
99.68
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CC1=NN(C(C(CC)CC)=CC(C)=N2)C2=C1C3=C(Cl)N=C(N4C([2H])([2H])C([2H])([2H])OC([2H])([2H])C4([2H])[2H])S3
Molecular Formula
C20H18D8ClN5OS
Molecular Weight
428.02
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
